Twitter Beğeni Hilesi

Excelente Phase 1 Meeting! Gracias Ignacio Matos y Eduardo Castañon por la invitación! En nombre de la Unidad START Fundación Jiménez Díaz

📢 España requiere una red de ensayos clínicos que permita su descentralización autonómica y ser líderes en Europa. Ignacio Matos Javier García Corbacho Elena Garralda Institut Català d'Oncologia Eduardo Castañon Victor Moreno cancercenter.cun.es/noticias/espan…

🔹Nuevo episodio de #TooMore‼️ Con los Dres. Angela Lamarca y Victor Moreno #vacunas #pancreas ¿Te lo vas a perder? transworldeditors.com/en/toomore-pod Puedes echarle un ojo a los estudios aquí 📷 nature.com/articles/s4158……nature.com/articles/s4159… TransworldHealth

Big milestone in cell therapy for solid tumors! Thrilled to share our work on the first cell therapy expected to be approved for synovial sarcoma. A step forward in cancer treatment. Proud to be part of this groundbreaking project! sciencedirect.com/science/articl…

Don’t miss our insightful poster presentations today at #AACR24 led by Dr. Michael Wick. Details below: (1/3)

Amazing meeting today with BMS #EUScientificInnovationSummit thanks Mar for a wonderful organization

Today we've dosed the first patient globally in the Phase I trial of NILK-2301, a novel bispecific targeting CEACAM5-CD3 for colon cancer, developed in partnership with Light Chain Bioscience and LamKap Bio Group. A big step forward in cancer immunotherapy! #CancerResearch

Check out our new website at START! startresearch.com Fundación Jiménez Díaz #CancerResearch

@HACLab_UPenn JMIR Publications Mitesh Patel Thyme Care Jasper Health Biofourmis Roxanne Jensen Julian Hong Penn Cancer Innovation Andrew Vickers Robin Zon, MD, FACP, FASCO Chris Manz Dept. of Biostatistics, Epidemiology & Informatics We're also interested in clinical decision-making. Check out Chris Manz Victor Moreno oral prez ASCO #ASCO24: "Prospective and external validation of an objective performance status (OPS) in patients with metastatic solid malignancies using wearable accelerometry."

Perfect timing 2024 will be the year of cell therapy for solid tumors (first FDA approval coming soon...) ;)

Yes, sorry I meant with modified cells (TCRs) not TILs...

You are right, but with TILs. My comment was for "modified cells" like CARTS (modified TCRs cell for the case of solid tumors) I hope this clarifies and thanks for pointing it out!

Significant milestone at our START Madrid FJD location! - The START Center Victor Moreno oncodaily.com/82714.html #CancerImmunotherapy #CancerResearch #CancerTreatment #OncoDaily #Oncology

Have you seen the latest feature in Health Tech World? Drs. Calvo & Victor Moreno of START featured & sharing insights on Spain's growth in oncology, patient access to clinical trials, and developments in personalized medicine 👏

Huge news! Adaptimmune's TECELRA® (afamitresgene autoleucel) just received FDA accelerated approval. It's the first engineered cell therapy approved for a solid tumor, targeting advanced synovial sarcoma #CancerTreatment #FDAApproval.businesswire.com/news/home/2024…

telemadrid.es/programas/tele… Fundación Jiménez Díaz Vacuna para el cáncer de pulmón en ensayo clínico de fase 1. Gracias Telemadrid por la difusión, seguimos avanzando. #Investigación

#ConSaludPodcasts|📻 ¡Buenos días! Hoy es miércoles, 28 de agosto de 2024 y entre las noticias destacamos: ➡️ La vacuna contra el #cáncerdepulmón ya está a prueba en España y los resultados son prometedores. Hablamos con Victor Moreno de la Fundación Jiménez Díaz 🖊️Javier Leunda

Now Live!!! START’s Virtual Panel Series featuring the hottest topics in oncology clinical research. Join us for our conversations on ADCs, malignant hematology, precision medicine, monoclonal antibodies, and more! startresearch.com/start-announce…